[Comparative crossover double-blind study of profenid and indomethacin patients with rheumatoid arthritis]. / Vergleichende Crossover-Doppelblindstudie mit Profenid und Indometazin bei Patienten mit Rheumatoid-Arthritis.

38 patients with active rheumatoid arthritis, randomly divided into two groups, underwent a three weeks treatment with profenid (3 capsules + 1 suppositorium) alternatively with indomethacin (3 capsules + 1 suppositorium), which head lasted six weeks in case of each patient. The study was double-blind using a crossover technique. The results show that the efficacy of the applied doses of profenid is similar to that of indomethacin. Profenid is superior to indomethacin with regard to drug tolerance.